The RECOVER Initiative is a research program run by the American National Institutes of Health that aims to understand the causes of, discover treatments for and prevent long COVID. RECOVER's initial studies were observational, but others focused on pathology of treatments have been performed. Plans for a series of treatment studies were announced in July 2023.[1]

References

  1. ↑ "NIH launches long COVID clinical trials through RECOVER Initiative, opening enrollment". National Institutes of Health (NIH). 2023-07-27. Retrieved 2023-08-22.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.